GT Biopharma (GTBP) has had the highest return since September 1, 2026 by a US stock, returning 3,924.2%.
| ASSET | % RETURN |
|---|---|
GT Biopharma (GTBP) | 3,924.22% |
Cytosorbents Crp (CTSO) | 1,717.37% |
Neurosense Therapeutics (NRSN) | 1,489.86% |
Pop Culture (CPOP) | 1,133.94% |
Hub Cyber Security Ltd Ordinary Shares (HUBC) | 931.76% |
Shengfeng Development Limited Class A Ordinary Shares (SFWL) | 735.63% |
TNL Mediagene Ordinary Shares (TNMG) | 553.89% |
NextNRG (NXXT) | 526.13% |
La Rosa Holdings Corp Common Stock (LRHC) | 441.63% |
Future Fintech (FTFT) | 336.96% |
Indaptus Therapeutics (INDP) | 185.45% |
error (ZVZZT) | 146% |
FAST TRACK (FTRK) | 100% |
Swvl (SWVL) | 95.39% |
PDS Biotechnology (PDSB) | 90.05% |
17 Education Technology (YQ) | 88.67% |
Elite Express Holding Inc Class A Common Stock (ETS) | 86.54% |
Diana Shipping Inc WT (DSX.WT) | 85.96% |
error (ATER) | 76.36% |
CEA Industries (BNC) | 75.67% |
Katapult (KPLT) | 71.3% |
Opus Genetics (IRD) | 63.56% |
ChargePoint (CHPT) | 60.73% |
Nutriband (NTRB) | 59.93% |
PS International Group Ltd Ordinary Shares (PSIG) | 59.75% |